Business

RavenQuest BioMed Names New Legal Counsel and Auditors

RavenQuest BioMed Names New Legal Counsel and Auditors.

articleRavenquest Biomed IncDecember 23, 20194/company/ravenquest-biomed-inc/news/ravenquest-biomed-names-new-legal-counsel-and-auditors
RavenQuest BioMed Names New Legal Counsel and Auditors

About this update from Ravenquest Biomed Inc

[{"type":"text","content":"\n VANCOUVER, British Columbia, Dec. 23, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”), today announced that, as part of the ongoing evolution of its corporate strategy, it has retained Farris LLP as its legal counsel and Dale Matheson Carr-Hilton Labonte LLP as its auditors. RavenQuest CEO, George Robinson, stated, “from a cannabis perspective, both Farris LLP and Dale Matheson Carr-Hilton Labonte LLP bring the experience, perspective and expertise we are looking for in our legal and auditing teams. In keeping with our ongoing theme of adding advisors with a deep level of knowledge in the cannabis space, we are very excited to bring both groups onboard in their respective advisory capacities.” For more information, access RavenQuest’s investor presentation, fact sheet and videos here. Follow RavenQuest:TwitterInstagramFacebookLinkedIn About RavenQuest BioMed Inc. RavenQuest is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development. RavenQuest is a licensed producer with facilities located in Markham, Ontario and Edmonton, Alberta. RavenQuest maintains a research partnership with McGill University focused upon cultivar (strain) recognition, plant stabilization and yield maximization of the cannabis plant. The Company also focuses on partnerships with Indigenous communities. On Behalf of the Board of Directors ofRAVENQUEST BIOMED INC. “George Robinson”Chief Executive Officer For further information, please contact: Mathieu McDonald, Corporate Communications1-877-282-1586 Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management. Cautionary Note Regarding Forward-Looking Statement All statements in this press release, other than statements of historical fact, are “forward-looking information” with respect to the Company within the meaning of applicable securities laws. The Company provides forward-looking statements for the purpose of conveying information about curren...

More updates from Ravenquest Biomed Inc